Clinical trial of IAVI’s lassa vaccine shows promise

A first-in-human Phase 1 clinical trial of IAVI’s Lassa virus (LASV) vaccine candidate has shown encouraging results, demonstrating robust

Pate reaffirms Nigeria, West Africa’s commitment to tackle lassa fever

by Nkechi Onyedika-Ugoeze, Abuja

by Lazarus Victory

by Nkechi Onyedika-Ugoeze, Abuja

by Nkechi Onyedika-Ugoeze, Abuja

by Musa Adekunle

by Musa Adekunle

by Musa Adekunle

by Gaudensia Mutua, M.D.

by Chukwuma Muanya

by Chukwuma Muanya

by Chukwuma Muanya

by Chukwuma Muanya

by Ann Godwin, Port Harcourt

by AFP

by Chukwuma Muanya

by Chukwuma Muanya, Assistant Editor